CHIT1 at Diagnosis Reflects Long‐Term Multiple Sclerosis Disease Activity-Reference-Cited by-同舟云学术

CHIT1 at Diagnosis Reflects Long‐Term Multiple Sclerosis Disease Activity

Published:2020-02-08 Issue:4 Volume:87 Page:633-645
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol

Author:

Oldoni Emanuela¹²,Smets Ide¹²³,Mallants Klara¹²,Vandebergh Marijne¹²,Van Horebeek Lies¹²,Poesen Koen²⁴,Dupont Patrick²⁵,Dubois Bénédicte¹²³,Goris An¹²^ORCID

Affiliation:

1. KU Leuven ‐ Department of Neurosciences, Laboratory for Neuroimmunology Leuven Belgium

2. Leuven Brain Institute, KU Leuven Leuven Belgium

3. Department of Neurology, University Hospitals Leuven Leuven Belgium

4. KU Leuven ‐ Department of Neurosciences, Laboratory for Molecular Neurobiomarker Research Leuven Belgium

5. KU Leuven ‐ Department of Neurosciences, Laboratory for Cognitive Neurology Leuven Belgium

Funder

European Committee for Treatment and Research in Multiple Sclerosis

Fondation Charcot

Fonds Wetenschappelijk Onderzoek

KU Leuven

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ana.25691

Reference53 articles.

1. Multiple sclerosis

2. A brief history of NEDA

3. Body fluid biomarkers in multiple sclerosis

4. Neurofilaments as biomarkers in neurological disorders

5. Gene Expression Profiling of Multiple Sclerosis Pathology Identifies Early Patterns of Demyelination Surrounding Chronic Active Lesions

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fluid biomarkers in multiple sclerosis: from current to future applications;The Lancet Regional Health - Europe;2024-09

2. CHIT1 at diagnosis predicts faster disability progression and reflects early microglial activation in multiple sclerosis;Nature Communications;2024-06-12

3. Identification of distinct and shared biomarker panels in different manifestations of cerebral small vessel disease through proteomic profiling;2024-06-10

4. Natalizumab promotes anti-inflammatory and repair effects in multiple sclerosis;PLOS ONE;2024-03-25

5. Identification of candidate biomarkers and pathways associated with multiple sclerosis using bioinformatics and next generation sequencing data analysis;2023-12-07